NFKB1 and cancer: To our knowledge, this is the first study demonstrating that activation of the IKK-NFκB pathway by IR can regulate the repair of DSBs and inhibition of IKKβ activity may sensitize cancer cells to IR at least in part via inhibition of DSB repair.